Protease activity: Meeting its theranostic potential

Theranostics

Volumn 2, Issue 2, 2012, Pages 125-126

  Lee, Seulki ^a   Kim, Kwangmeyung ^b  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Biomarkers; Diagnosis; Drug development; Molecular imaging; Proteases; Theranostics

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CATHEPSIN B; GOLD NANOPARTICLE; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; QUANTUM DOT; SIGNAL PEPTIDE;

APOPTOSIS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CANCER DIAGNOSIS; CANCER THERAPY; CARDIOVASCULAR DISEASE; DIAGNOSTIC KIT; DISEASE MARKER; EDITORIAL; ENZYME ACTIVITY; ENZYMIC BIOSENSOR; ESOPHAGEAL ADENOCARCINOMA; HUMAN; IN VIVO STUDY; INFLAMMATORY DISEASE; KNEE; MEDICAL RESEARCH; MOLECULAR IMAGING; MOLECULAR PROBE; NEOPLASM; NEUROLOGIC DISEASE; OSTEOARTHRITIS; PHOTODYNAMIC THERAPY; PROTEIN DEGRADATION; SYNOVIAL FLUID;

EID: 84864563925     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.4129     Document Type: Editorial

References (14)

1. Lopez-Otin C and Bond JS. Proteases: Multifunctional enzymes in life and disease. J Biol Chem. 2008; 283: 30433-7.
2. Turk B. Targeting Proteases: Successes, failures and future prospects. Nat Rev Drug Discov. 2006; 5: 785-99.
3. Rautio J, Kumpulainen H, Heimbach T, et al. Prodrugs: Design and clinical applications. Nat Rev Drug Discov. 2008; 7: 255-70.
4. Choi KY, Swierczewska M, Lee S, et al. Protease-activated drug development. Theranostics. 2012; 2: in press.
5. Zhu L, Xie J, Swierczewska M, et al. Real-time video imaging of protease expression in vivo. Theranostics. 2011; 1: 18-27.
6. Kim GB and Kim Y-P. Analysis of protease activity using quantum dots and resonance energy transfer. Theranostics. 2012; 2: 10.7150/thno.3476.
7. Chen Y and Liang G. Enzymatic self-assembly of nanostruc-tures for theranostics. Theranostics. 2012; 2: 10.7150/thno.3696.
8. Chen HH, Yuan H, Josephson L, et al. Theranostic imaging of the kinases and proteases that modulate cell death and survival. Theranostics. 2012; 2: in press.
9. Yhee JY, Kim SA, Koo H, et al. Optical imaging of cancer-related proteases using near-infrared fluorescence matrix metalloproteinase-sensitive and cathepsin b-sensitive probes. Theranostics. 2012; 2: 10.7150/thno.3716.
10. Jang B and Choi Y. Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy. Theranostics. 2012; 2: 10.7150/thno.3478.
11. Ryu JH, Lee A, Huh MS, et al. Measurement of mmp activity in synovial fluid in cases of osteoarthritis and acute inflammatory conditions of the knee joints using a fluorogenic peptide probe-immobilized diagnostic kit. Theranostics. 2012; 2: 10.7150/thno.3477.
12. Ozaki M, Haga S, and Ozawa T. In vivo monitoring of liver damage using caspase-3 probe. Theranostics. 2012; 2: 10.7150/thno.3806.
13. Savitsky AP, Rusanov AL, Zherdeva VV, et al. Flim-fret imaging of caspase-3 activity in live cells using pair of red fluorescent proteins. Theranostics. 2012; 2: in press.
14. Habibollahi P, Figueiredo J-L, Heidari P, et al. Optical imaging with a cathepsin b activated probe for the enhanced detection of esophageal adenocarcinoma by dual channel fluorescent upper gi endoscopy. Theranostics. 2012; 2: in press.